• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

exploring innovative therapeutic target for bone metastatic prostate cancer based on analysis of molecular mechanism.

Research Project

Project/Area Number 18K09168
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 56030:Urology-related
Research InstitutionEhime University

Principal Investigator

SAIKA TAKASHI  愛媛大学, 医学系研究科, 教授 (10314676)

Co-Investigator(Kenkyū-buntansha) 今井 祐記  愛媛大学, プロテオサイエンスセンター, 教授 (10423873)
菊川 忠彦  愛媛大学, 医学系研究科, 准教授 (70444734)
三浦 徳宣  愛媛大学, 医学部附属病院, 講師 (80554427)
Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords前立腺癌 / 骨転移 / 前立腺がん / 転移制御 / 分子機構 / データベース
Outline of Final Research Achievements

The prognosis of patients with progressive prostate cancers that are hormone refractory and/or have bone metastasis is poor. we identified G Protein-Coupled Receptor Class C Group 5 Member A (GPRC5A) as a candidate therapeutic molecule using integrative gene expression analyses of registered data sets for prostate cancer cell lines. Kaplan Meier analysis of TCGA data sets revealed that patients who have high GPRC5A expression had significantly shorter overall survival. PC3 prostate cancer cells with CRISPR/Cas9-mediated GPRC5A knockout exhibited significantly reduced cell proliferation both in vitro and in vivo. RNA-seq revealed that GPRC5A KO PC3 cells had dysregulated expression of cell cycle-related genes, leading to cell cycle arrest at the G2/M phase. Furthermore, GPRC5A KO PC3 cells failed to establish bone metastasis in xenograft mice models. Our findings indicate that GPRC5A can be a possible therapeutic target and prognostic marker molecule for progressive prostate cancer.

Academic Significance and Societal Importance of the Research Achievements

本研究の成果により、前立腺癌進展の病態の解明と新規治療方法および骨転移の予防や骨転移発生の予測の治療基盤の構築が進むと期待できる。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (13 results)

All 2020 2019 2018 Other

All Int'l Joint Research (3 results) Journal Article (1 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 1 results) Presentation (8 results) (of which Int'l Joint Research: 1 results,  Invited: 2 results) Patent(Industrial Property Rights) (1 results)

  • [Int'l Joint Research] Institute of Enzymology(ハンガリー)

    • Related Report
      2020 Annual Research Report
  • [Int'l Joint Research] Cancer Biomarker Research Group/Institute of Enzymology/Hungarian Academy of Sciences(ハンガリー)

    • Related Report
      2019 Research-status Report
  • [Int'l Joint Research] Cancer Biomarker Research Group/Institute of Enzymology/Hungarian Academy of Sciences(ハンガリー)

    • Related Report
      2018 Research-status Report
  • [Journal Article] GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer2020

    • Author(s)
      Sawada Y, Kikugawa T, Iio H, Sakakibara I, Yoshida S, Ikedo A, Yanagihara Y, Saeki N, Gyorffy B, Kishida T, Okubo Y, Nakamura Y, Miyagi Y, Saika T, Imai Y.
    • Journal Title

      International Journal of Cancer

      Volume: 146 Issue: 5 Pages: 1369-1382

    • DOI

      10.1002/ijc.32554

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Presentation] ゲノムワイド統合解析による運動器疾患治療標的の探索2020

    • Author(s)
      今井祐記
    • Organizer
      第35回日本整形外科学会基礎学術集会
    • Related Report
      2020 Annual Research Report
    • Invited
  • [Presentation] Mechanisms underlying prostate cancer bone metastasis identified by big data analyses2020

    • Author(s)
      Yuuki Imai
    • Organizer
      47th European Calcified Tissue Society Congress
    • Related Report
      2020 Annual Research Report
    • Invited
  • [Presentation] GPRC5A facilitates cell proliferation and bone metastasis of prostate cancer2019

    • Author(s)
      沢田雄一郎 菊川忠彦 飯尾浩之 榊原伊織 吉田周平 池戸葵  柳原裕太 佐伯法学 Balaz Gyorffy 岸田健 大久保陽一郎 中村圭靖 宮城洋平 雑賀隆史 今井祐記
    • Organizer
      第37回日本骨代謝学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] GPRC5A facilitates cell proliferation and bone metastasis of prostate cancer2019

    • Author(s)
      沢田雄一郎 菊川忠彦 飯尾浩之 榊原伊織 吉田周平 池戸葵  柳原裕太 佐伯法学 Balazs Gyorffy 岸田健 大久保陽一郎 中村圭靖 宮城洋平 雑賀隆史 今井祐記
    • Organizer
      第71回西日本泌尿器科学会総会
    • Related Report
      2019 Research-status Report
  • [Presentation] GPRC5Aは前立腺癌の細胞増殖および骨転移を制御する2019

    • Author(s)
      沢田雄一郎 菊川忠彦 飯尾浩之 榊原伊織 吉田周平 池戸葵  柳原裕太 佐伯法学 Balazs Gyorffy 岸田健 大久保陽一郎 中村圭靖 宮城洋平
    • Organizer
      第28回泌尿器科分子・細胞研究会
    • Related Report
      2018 Research-status Report
  • [Presentation] GPRC5A facilitates cell proliferation and bone metastasis of prostate cancer2019

    • Author(s)
      沢田雄一郎 菊川忠彦 飯尾浩之 榊原伊織 吉田周平 池戸葵  柳原裕太 佐伯法学 Balazs Gyorffy 岸田健 大久保陽一郎 中村圭靖 宮城洋平
    • Organizer
      The 34th Annual European Association of Urology Congress
    • Related Report
      2018 Research-status Report
    • Int'l Joint Research
  • [Presentation] 前立腺がん骨転移制御分子の解析2018

    • Author(s)
      沢田雄一郎 菊川忠彦 飯尾浩之 榊原伊織 吉田周平 池戸葵  柳原裕太 佐伯法学 Balazs Gyorffy 岸田健 大久保陽一郎 中村圭靖 宮城洋平
    • Organizer
      第9回Orthopedic Research Club
    • Related Report
      2018 Research-status Report
  • [Presentation] 前立腺癌骨転移の新規治療標的分子PCBM1の同定2018

    • Author(s)
      沢田雄一郎 菊川忠彦 飯尾浩之 榊原伊織 吉田周平 池戸葵  柳原裕太 佐伯法学 Balazs Gyorffy 岸田健 大久保陽一郎 中村圭靖 宮城洋平
    • Organizer
      第27回泌尿器科分子・細胞研究会
    • Related Report
      2018 Research-status Report
  • [Patent(Industrial Property Rights)] 前立腺癌の骨転移判定方法2018

    • Inventor(s)
      今井祐記、雑賀隆史、菊川忠彦、沢田雄一郎
    • Industrial Property Rights Holder
      株式会社プラスパブレインズ、今井祐記
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2018-198404
    • Filing Date
      2018
    • Related Report
      2018 Research-status Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi